WALNUT HOME THERAPEUTICS INC, of PHILADELPHIA, PA, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $182.9M in revenue, $166.5M in expenses, $73.9M in total assets.
WALNUT HOME THERAPEUTICS PROVIDES MEDICATIONS IN THE HOME TO ASSIST IN TRANSITIONING PATIENTS FROM A HOSPITAL OR SKILLED FACILITY TO INDEPENDENT LIVING, PRIMARILY THROUGH INTRAVENOUS DRUG DELIVERY METHODOLOGIES, IN SUPPORT OF TJUH AND OTHER PHILADELPHIA AREA HOSPITALS, AND SERVES AS A SPECIALTY PHARMACY THAT PROVIDES A UNIQUE SERVICE TO CLINICALLY COMPLEX PATIENTS. SPECIALTY MEDICATIONS ARE TYPICALLY BIOTECHNOLOGY-DERIVED MEDICATIONS THAT TREAT RARE AND CHRONIC CONDITIONS.
How Walnut Home Therapeutics Inc divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $182.9M | $166.5M | $73.9M |
| 2024 | $72.2M | $78.7M | $64.2M |
| 2023 | $85.5M | $85.3M | $63.4M |
| 2022 | $80.8M | $81.3M | $64.1M |
| 2021 | $70.9M | $75.8M | $66.7M |
Between 2021 and 2025, reported annual revenue grew from $70.9M to $182.9M (+158%), with total assets most recently reported at $73.9M.
Interactive year-over-year charts and full filing details available with membership.
